Novel lung cancer molecular marker retinoic acid receptor response protein 2
A technology of liver cancer cells and drugs, which is applied to the application field of retinoic acid receptor response protein 2 and its C-terminal active fragment in cancer prevention and treatment, can solve the problem that the role and mechanism are rarely reported.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0052] The chemerin used in the present invention includes the polypeptide containing the amino acid sequence shown in SEQ ID NO: 2 (the 1st to 20th positions are signal peptides) and its active fragments retaining the biological activity of chemerin.
[0053] The chemerin of the present invention also includes a variant form of the sequence of SEQ ID NO: 2 that has the same function as the chemerin protein. These variations include (but are not limited to): several (usually 1-50, preferably 1-30, more preferably 1-20, optimally 1-10, and more preferably 1 - 8, 1-5) amino acid deletions, insertions and / or substitutions, and addition of one or several (usually within 20, preferably within 10, more at the C-terminal and / or N-terminal Preferably within 5) amino acids. For example, in the art, substitutions with amino acids with similar or similar properties generally do not change the function of the protein. As another example, adding one or several amino acids at the C-termin...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 